Please assess the completion status of the following clinical trial:

Trial Title: Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 21+ years old~* Chronic ResMed ASV therapy patient~* Current ASV therapy for at least 4 weeks~* Able to understand fully the study information and participation requirements~* Provide signed informed consent~Exclusion Criteria:~* Acute cardiac decompensation~* Acute myocardial infarction within last 3 months~* Resuscitation within last 3 months~* Stroke with swallowing disorders or persistent hemiparesis~* Blood pressure test at end expiratory pressure (EEP) 10cmH2O not passed~* Untreated restless legs syndrome~* Alcohol or drug abuse~* Known cancer~* Pregnancy~* Conditions that could interfere with patients participating in and completing the protocol and/or the investigator deems their enrolment unsuitable

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Modified ASV (Type: EXPERIMENTAL): Modified ASV Enhanced ASV algorithm which includes auto-adjusting expiratory pressure.
- Conventional ASV (Type: ACTIVE_COMPARATOR): Conventional ASV This is the current (predicate) ASV algorithm.

Based on this trial design, predict the completion outcome and termination type (if applicable).